Merit Medical Systems Management
Management criteria checks 4/4
Merit Medical Systems' CEO is Fred Lampropoulos, appointed in Jul 1987, has a tenure of 37.92 years. total yearly compensation is $10.38M, comprised of 18.2% salary and 81.8% bonuses, including company stock and options. directly owns 1.88% of the company’s shares, worth $102.33M. The average tenure of the management team and the board of directors is 7.1 years and 5 years respectively.
Key information
Fred Lampropoulos
Chief executive officer
US$10.4m
Total compensation
| CEO salary percentage | 18.21% |
| CEO tenure | 37.9yrs |
| CEO ownership | 1.9% |
| Management average tenure | 7.1yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
Merit Medical Systems: A Quality Business Judged On Its Merits
May 22Risks To Shareholder Returns Are Elevated At These Prices For Merit Medical Systems, Inc. (NASDAQ:MMSI)
May 21
We Take A Look At Why Merit Medical Systems, Inc.'s (NASDAQ:MMSI) CEO Has Earned Their Pay Packet
May 07Merit Medical Systems' (NASDAQ:MMSI) Returns On Capital Are Heading Higher
Apr 11Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Mar 30Here's Why We Think Merit Medical Systems (NASDAQ:MMSI) Is Well Worth Watching
Mar 18Merit Medical: A Success Story That Keeps Getting Better
Mar 16A Look At The Fair Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)
Mar 06Merit Medical Systems (NASDAQ:MMSI) Seems To Use Debt Rather Sparingly
Feb 10Why We're Not Concerned About Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Share Price
Jan 17Merit Medical Systems: Solid Execution, Stretched Valuations
Jan 08Returns Are Gaining Momentum At Merit Medical Systems (NASDAQ:MMSI)
Dec 23Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Dec 11Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?
Nov 29Merit Medical Systems, Inc. (NASDAQ:MMSI) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Nov 02Is Merit Medical Systems (NASDAQ:MMSI) A Risky Investment?
Nov 01Merit Medical Systems - Impressive Momentum
Sep 17The Price Is Right For Merit Medical Systems, Inc. (NASDAQ:MMSI)
Sep 17Why Merit Medical Systems, Inc. (NASDAQ:MMSI) Could Be Worth Watching
Sep 04
China Market And New Products Propel Medical Equipment Giant To New Heights
Enhanced international market performance, notably in China, hints at potential market share and revenue increases.Merit Medical Systems (NASDAQ:MMSI) Is Doing The Right Things To Multiply Its Share Price
Aug 22These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely
Jul 31Merit Medical Systems: Steady Wins The Day
Jul 05Merit Medical: Undervalued With Multiple Growth Drivers In Play
Jun 15Merit Medical Systems: Solid Performer, Fully Valued
Mar 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | US$122m |
| Dec 31 2024 | US$10m | US$2m | US$120m |
| Sep 30 2024 | n/a | n/a | US$120m |
| Jun 30 2024 | n/a | n/a | US$117m |
| Mar 31 2024 | n/a | n/a | US$102m |
| Dec 31 2023 | US$10m | US$2m | US$94m |
| Sep 30 2023 | n/a | n/a | US$100m |
| Jun 30 2023 | n/a | n/a | US$90m |
| Mar 31 2023 | n/a | n/a | US$85m |
| Dec 31 2022 | US$8m | US$2m | US$75m |
| Sep 30 2022 | n/a | n/a | US$62m |
| Jun 30 2022 | n/a | n/a | US$58m |
| Mar 31 2022 | n/a | n/a | US$48m |
| Dec 31 2021 | US$8m | US$2m | US$48m |
| Sep 30 2021 | n/a | n/a | US$43m |
| Jun 30 2021 | n/a | n/a | US$28m |
| Mar 31 2021 | n/a | n/a | US$4m |
| Dec 31 2020 | US$8m | US$2m | -US$10m |
| Sep 30 2020 | n/a | n/a | -US$29m |
| Jun 30 2020 | n/a | n/a | -US$30m |
| Mar 31 2020 | n/a | n/a | -US$4m |
| Dec 31 2019 | US$5m | US$2m | US$5m |
| Sep 30 2019 | n/a | n/a | US$19m |
| Jun 30 2019 | n/a | n/a | US$39m |
| Mar 31 2019 | n/a | n/a | US$43m |
| Dec 31 2018 | US$4m | US$2m | US$42m |
Compensation vs Market: Fred's total compensation ($USD10.38M) is about average for companies of similar size in the US market ($USD8.76M).
Compensation vs Earnings: Fred's compensation has been consistent with company performance over the past year.
CEO
Fred Lampropoulos (75 yo)
Mr. Fred P. Lampropoulos has been the President of BioSphere Medical, Inc. since September 2010. He has been the President at Merit Medical Systems, Inc. since January 03, 2025. He is Founder of Merit Medi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 37.9yrs | US$10.38m | 1.88% $ 102.3m | |
| CFO & Treasurer | 7.1yrs | US$3.17m | 0.023% $ 1.3m | |
| Chief Operating Officer | 3.2yrs | US$3.14m | 0.028% $ 1.5m | |
| Chief Legal Officer & Corporate Secretary | 9.2yrs | US$3.10m | 0.037% $ 2.0m | |
| Chief Information Officer | 2.4yrs | no data | no data | |
| Vice President of Global Communications | no data | no data | no data | |
| Chief Human Resources Officer | 4.5yrs | no data | 0.021% $ 1.1m | |
| Chief Regulatory Affairs Officer | 12.4yrs | no data | no data | |
| Managing Director of Operation Merit Medical Tijuana | no data | no data | no data | |
| Executive Vice President of Merit Medical EMEA | no data | no data | no data | |
| Sustainability Council Chair and Vice President of Environment | no data | no data | no data | |
| Executive Vice President of Manufacturing Finance & Strategy | no data | no data | no data |
Experienced Management: MMSI's management team is seasoned and experienced (7.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 37.9yrs | US$10.38m | 1.88% $ 102.3m | |
| Independent Director | 3.1yrs | US$285.97k | 0.0072% $ 390.3k | |
| Independent Director | 5yrs | US$295.35k | 0.022% $ 1.2m | |
| Lead Independent Director | 9.9yrs | US$330.97k | 0.051% $ 2.8m | |
| Independent Director | 3.1yrs | US$285.97k | 0.0090% $ 488.7k | |
| Independent Director | 8.1yrs | US$300.97k | 0.053% $ 2.9m | |
| Independent Director | 5yrs | US$300.97k | 0.022% $ 1.2m | |
| Independent Director | 5.8yrs | US$305.97k | 0.014% $ 756.7k | |
| Independent Director | 4yrs | US$285.97k | 0.0038% $ 204.9k | |
| Independent Director | 1.1yrs | US$253.72k | 0% $ 0 |
Experienced Board: MMSI's board of directors are considered experienced (5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/23 13:46 |
| End of Day Share Price | 2025/06/20 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Merit Medical Systems, Inc. is covered by 22 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Rescott | Baird |
| Ishan Majumdar | Baptista Research |
| Michael Petusky | Barrington Research Associates, Inc. |